• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-08-29

  A 2024 study found that moxidectin increases Candida albicans ergosterol production, thereby enhancing the activity of amphotericin B and nystatin against planktonic cells, biofilms, and oral infection in mice. The work proposes target amplification at the fungal membrane as a mechanism for improving polyene efficacy while using lower antifungal exposure.

• Imatinib (STI571) Workflow for Kinase Research

  2026-08-29

  Imatinib (STI571) provides a practical benchmark for dissecting Abl, c-Kit, and PDGF receptor signaling across phosphorylation, proliferation, and migration assays. This workflow shows how to use its defined potency, matched controls, and orthogonal readouts to distinguish pathway inhibition from nonspecific toxicity.

• Okadaic acid: PP1/PP2A Assay Guide

  2026-08-28

  Okadaic acid (SKU A4540) provides concentration-dependent inhibition of PP2A and PP1 for phosphorylation, signaling, and apoptosis workflows. It is appropriate for targeted phosphatase perturbation, but not for broad-spectrum phosphatase suppression or for assigning a universal cellular apoptosis dose without local optimization.

• TRPV1 and TRPA1 Drive TSLP in Nasal Epithelium

  2026-08-28

  The reference study shows that TRPV1 and TRPA1 are expressed by nasal epithelial cells and that their activation promotes TSLP production through calcium-dependent NFAT signaling. The findings connect environmental sensory cues with epithelial inflammatory signaling and provide a mechanistic framework for studying upper-airway inflammation and TRPA1 ion channel modulation.

• DOM, 5-HT Receptors, and Biphasic Mouse Behavior

  2026-08-27

  The reference study shows that DOM-induced head twitching and locomotor activity share a dominant 5-HT2A component but are shaped differently by 5-HT2C, 5-HT1A, and Gi/o signaling. Its pharmacological design separates receptor mechanisms underlying the inverted U-shaped behavioral curves, providing a useful framework for interpreting dose-dependent psychedelic effects in mice.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-27

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations from the same tumor. The model reproduced tumor heterogeneity, altered inflammatory and extracellular-matrix programs, and revealed that stromal context can change drug sensitivity, supporting more physiologically relevant cancer research and personalized treatment studies.

• EZ Cap™ Cy5 EGFP mRNA for LNP Assays

  2026-08-26

  Discover how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from functional translation in advanced LNP studies. This dual-fluorescence framework connects reporter assays with biophysical measurements of nanoparticle heterogeneity.

• IEM 1460: AMPA Receptor Blockade Workflows

  2026-08-26

  IEM 1460 is a selective AMPA receptor blocker for separating fast glutamatergic signaling from downstream excitotoxic injury. This practical guide connects assay setup, electrophysiology, neuroprotection readouts, and troubleshooting while distinguishing AMPA-selective experiments from dual-receptor seizure research.

• Chemistry of Silybin: Structure and Derivatives

  2026-08-25

  Křen and colleagues’ review organizes more than five decades of research on silybin, a principal flavonolignan from milk thistle, around its structure, stereochemistry, separation, synthesis, and derivative chemistry. Its practical value is a chemistry-first framework for distinguishing purified silybin from the multicomponent extract silymarin when interpreting analytical, mechanistic, and bioactivity data.

• α-Eudesmol and ω-Agatoxin IVA in Focal Ischemia

  2026-08-25

  The reference study connects inhibition of ω-agatoxin IVA-sensitive presynaptic calcium channels with reduced glutamate accumulation, edema, and infarction after focal cerebral ischemia. Its combination of synaptosome assays, middle cerebral artery occlusion, triphenyltetrazolium chloride staining, and microdialysis provides a pharmacological framework for studying calcium-dependent excitotoxicity and neuroprotection.

• Deferasirox Fe3+ Chelate for Myeloid Assays

  2026-08-24

  Use Deferasirox Fe3+ chelate to model a defined ferric-iron state in myeloid differentiation, mitochondrial ROS, and NF-κB experiments. This workflow separates iron-bound-complex effects from the biology of free deferasirox while providing practical controls for solubility, oxygen tension, and cell maturation.

• IEM-1925 in Soman-Induced Status Epilepticus

  2026-08-23

  A 2026 rat study shows that IEM-1925, which targets AMPA and NMDA glutamate receptors, reduced soman-induced status epilepticus, hippocampal injury, and behavioral deficits more consistently than diazepam in the reported model. The work supports glutamatergic signaling as a therapeutic target while highlighting the need to distinguish dual-receptor treatment effects from selective AMPA-receptor mechanisms.

• Lactobacillus acidophilus–UDCA in Ulcerative Colitis

  2026-08-22

  Deng et al. show that Lactobacillus acidophilus may alleviate ulcerative colitis through a microbiota-dependent metabolite pathway centered on ursodeoxycholic acid. The study links UDCA with enhanced Treg differentiation, suppression of M1 macrophage polarization, and regulation of RapGap/PI3K-AKT/NF-κB signaling, while also identifying important limitations for translation beyond mouse models.

• GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus

  2026-08-21

  The reference study identifies MuGSTs1-mediated antioxidant defense as a functional contributor to lambda-cyhalothrin resistance in Megalurothrips usitatus. By combining RT-qPCR, biochemical measurements, apoptosis-related readouts, and diethyl maleate-based GST inhibition, the researchers connected GST activity with oxidative-stress tolerance and insecticide susceptibility.

• Polygodial: Designing Causal TRPA1 Assays

  2026-08-21

  Polygodial enables controlled TRPA1 channel activation in sensory and epithelial models. This article presents a causal assay framework that separates channel activity, calcium signaling, and inflammatory transcription for more interpretable ion-channel research.

446 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page